Pharma & CROs

Patients can be found and still disappear before the next step

You can identify patients and still lose them before treatment, PSP enrollment or evidence capture. In Latin America, patients often live far from specialist centers, and much of the journey happens outside the clinical record.

Discuss your program
Pause video

Where do pharma, biotech and CRO teams use Rarus Health?

Rarus works at three points where identified patients disappear before treatment, evidence or PSP enrollment.

After screening and patient identification

Identify where patients drop out
The problem

Screening, testing and access programs identify patients. Identification is not treatment. Patients miss referrals, lack documents or never reach the next clinical step.

How Rarus Health helps

Rarus keeps the journey visible after patient finding, so your team sees where patients drop out and what support they need before treatment or PSP enrollment.

A good fit when
  • A new therapy is launching
  • A screening or patient-finding program is starting
  • Patients are identified but do not reach treatment start

Before a patient support program can start

Identify where patients drop out
The problem

A traditional PSP usually starts around a medicine, after a prescription or access approval. Patients need support earlier: after diagnosis, during referral and while waiting for authorization.

How Rarus Health helps

Rarus starts around the person and the diagnosis, before the drug-centered program can begin. It helps patients reach the point where a PSP or treatment start becomes possible.

A good fit when
  • A PSP exists but starts too late
  • Diagnosed patients never enter the PSP
  • Access and documentation barriers come before drug onboarding

Patient engagement for outcomes and real-world evidence

Identify where patients drop out
The problem

Outcome-based agreements, post-marketing studies and clinical studies fail when patients stop responding, miss visits or leave questionnaires incomplete.

How Rarus Health helps

Outcomes and real-world evidence depend on patients staying reachable. Rarus keeps the relationship active so signals from real life do not disappear. Companies receive aggregated, anonymized insight only.

A good fit when
  • An outcome-based agreement requires follow-up
  • A post-marketing or natural-history study needs patient input
  • A clinical study needs to reduce dropout

What you can start with

Put a Care Manager on the next step your patients are missing.

Start with one defined patient group and one continuity challenge. Rarus Health runs the service; your team agrees the scope and the escalation rules.

A mother cares for her daughter, who is resting at home with a fever.

  1. Choose a care gap

    Identify the step in the patient journey that needs support.

  2. Agree the program

    Define eligibility, responsibilities, consent and reporting.

  3. Launch with Rarus Health

    Rarus Health Care Managers deliver the agreed follow-up on WhatsApp. AI handles routine check-ins and reminders.

Rarus turns patient messages, documents and check-ins into care signals: what happened, what may need to happen next, what blocked it and who needs to know.

Rarus supports navigation, follow-up and continuity. Clinical decisions stay with the care team.

Discuss a pilot